Prostaglandin E1
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 0)

H-INDEX

(FIVE YEARS 0)

Published By Springer Berlin Heidelberg

9783540545248, 9783642769108

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Effect of Intra-arterial and Intravenous Application of Prostaglandin E1 on Neutrophil Function in Peripheral Arterial Occlusive Disease

Prostaglandin E1 ◽

10.1007/978-3-642-76910-8_7 ◽

1991 ◽

pp. 49-57

Author(s):

F.-J. Neumann ◽

T. Weiss ◽

J. Mollenhauer ◽

M. Schneider ◽

I. Ott ◽

...

Keyword(s):

Peripheral Arterial Occlusive Disease ◽

Prostaglandin E1 ◽

Neutrophil Function ◽

Arterial Occlusive Disease ◽

Occlusive Disease ◽

Intravenous Application ◽

Peripheral Arterial

Download Full-text

Comparable Inhibitory Action of PGE1 and 13,14-dihydro-PGE1 on Smooth Muscle Cell Activity and Extracellular Matrix Production

Prostaglandin E1 ◽

10.1007/978-3-642-76910-8_5 ◽

1991 ◽

pp. 33-38

Author(s):

I. Neumann ◽

P. Fitscha ◽

J. O’grady ◽

B. A. Peskar ◽

H. Sinzinger

Keyword(s):

Extracellular Matrix ◽

Smooth Muscle ◽

Smooth Muscle Cell ◽

Muscle Cell ◽

Inhibitory Action ◽

Cell Activity ◽

Extracellular Matrix Production ◽

Matrix Production

Download Full-text

Effects of Intravenous PGE1 on Blood Flow and Microcirculation: A Double-Blind, Placebo-Controlled Study in Patients with Critical Limb Ischaemia

Prostaglandin E1 ◽

10.1007/978-3-642-76910-8_11 ◽

1991 ◽

pp. 91-100 ◽

Cited By ~ 2

Author(s):

P. Scheffler ◽

D. de la Hamette ◽

G. Leipnitz ◽

J. Gross

Keyword(s):

Blood Flow ◽

Critical Limb Ischaemia ◽

Controlled Study ◽

Limb Ischaemia ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Transcutaneous Oxygen Pressure at Different Dosages of Intravenous Prostaglandin E1 in Patients with Severe Arterial Occlusive Disease: A Double-Blind, Placebo-Controlled Study

Prostaglandin E1 ◽

10.1007/978-3-642-76910-8_9 ◽

1991 ◽

pp. 72-81

Author(s):

A. Creutzig ◽

L. Caspary ◽

K. Alexander

Keyword(s):

Oxygen Pressure ◽

Prostaglandin E1 ◽

Arterial Occlusive Disease ◽

Occlusive Disease ◽

Controlled Study ◽

Double Blind ◽

Transcutaneous Oxygen ◽

Double Blind Placebo ◽

Transcutaneous Oxygen Pressure

Download Full-text

Actions of PGE1, PGE0 and 15-keto-PGE1 on Vessel Tone in Vitro

Prostaglandin E1 ◽

10.1007/978-3-642-76910-8_3 ◽

1991 ◽

pp. 12-20 ◽

Cited By ~ 1

Author(s):

M. Braun ◽

L. Bruch ◽

P. Ney ◽

G. Torsello ◽

K. Schrör

Download Full-text

Transcutaneous PO2 During Intra-arterial and Intravenous PGE1 Infusion in Patients with Critical Limb Ischaemia

Prostaglandin E1 ◽

10.1007/978-3-642-76910-8_10 ◽

1991 ◽

pp. 82-90

Author(s):

T. Weiss ◽

J. Griesshaber ◽

W. Rogatti ◽

O. Kistner ◽

E. Hsu ◽

...

Keyword(s):

Critical Limb Ischaemia ◽

Limb Ischaemia ◽

Transcutaneous Po2

Download Full-text

On the Metabolism and Pharmacokinetics of Prostaglandin E1 Administered by Intra-arterial or Intravenous Infusions

Prostaglandin E1 ◽

10.1007/978-3-642-76910-8_2 ◽

1991 ◽

pp. 6-11

Author(s):

B. A. Peskar ◽

W. H. Hesse ◽

W. Rogatti ◽

G. Rudofsky

Keyword(s):

Prostaglandin E1 ◽

Intravenous Infusions

Download Full-text

PGE1 and 13,14-dihydro-PGE1 Increase Low-Density Lipoprotein Receptors and Improve Arterial Wall Lipid Metabolism

Prostaglandin E1 ◽

10.1007/978-3-642-76910-8_6 ◽

1991 ◽

pp. 39-48 ◽

Cited By ~ 1

Author(s):

H. Sinzinger ◽

I. Virgolini ◽

G. Lupattelli ◽

M. Banyai

Keyword(s):

Lipid Metabolism ◽

Arterial Wall ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Low Density ◽

Lipoprotein Receptors

Download Full-text

13,14-dihydro-PGE1 (PGE0) but not 15-keto-PGE1 is a Potent Inhibitor of Human Platelet and Neutrophil Activation

Prostaglandin E1 ◽

10.1007/978-3-642-76910-8_4 ◽

1991 ◽

pp. 21-32

Author(s):

P. Ney ◽

M. Braun ◽

C. Szymanski ◽

K. Schrör

Keyword(s):

Potent Inhibitor ◽

Human Platelet ◽

Neutrophil Activation

Download Full-text

A Comparison of Different Dosages of Intra-arterial and Intravenous Administered Prostaglandin E1 in Healthy Volunteers

Prostaglandin E1 ◽

10.1007/978-3-642-76910-8_8 ◽

1991 ◽

pp. 58-71

Author(s):

G. Rudofsky ◽

B. A. Peskar

Keyword(s):

Healthy Volunteers ◽

Prostaglandin E1

Download Full-text

Prostaglandin E1Latest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Springer Berlin Heidelberg

Effect of Intra-arterial and Intravenous Application of Prostaglandin E1 on Neutrophil Function in Peripheral Arterial Occlusive Disease

Comparable Inhibitory Action of PGE1 and 13,14-dihydro-PGE1 on Smooth Muscle Cell Activity and Extracellular Matrix Production

Effects of Intravenous PGE1 on Blood Flow and Microcirculation: A Double-Blind, Placebo-Controlled Study in Patients with Critical Limb Ischaemia

Transcutaneous Oxygen Pressure at Different Dosages of Intravenous Prostaglandin E1 in Patients with Severe Arterial Occlusive Disease: A Double-Blind, Placebo-Controlled Study

Actions of PGE1, PGE0 and 15-keto-PGE1 on Vessel Tone in Vitro

Transcutaneous PO2 During Intra-arterial and Intravenous PGE1 Infusion in Patients with Critical Limb Ischaemia

On the Metabolism and Pharmacokinetics of Prostaglandin E1 Administered by Intra-arterial or Intravenous Infusions

PGE1 and 13,14-dihydro-PGE1 Increase Low-Density Lipoprotein Receptors and Improve Arterial Wall Lipid Metabolism

13,14-dihydro-PGE1 (PGE0) but not 15-keto-PGE1 is a Potent Inhibitor of Human Platelet and Neutrophil Activation

A Comparison of Different Dosages of Intra-arterial and Intravenous Administered Prostaglandin E1 in Healthy Volunteers

Prostaglandin E1
Latest Publications